FDA approves Darzalex's new method of administration
-
Last Update: 2020-06-10
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
recently, Jansen announcedthe FDA(http://approve daratumab's new administration, the first dose (16 mg/kg) can be completed in two consecutive days of intravenous infusion, professionalmedical(http://caregivers and patients with multiple myeloma to choose according to the needsAbout Daratumab
Daratumumab was the first CD38 monoclonal antibody approved in the United States to treat multiple myeloma, first as a four-line treatmentdrug(http://in November 2015, followed by new indications, and finally became the first first-line treatment for multiple myeloma patients with inappropriate autologous stem cell transplants in May 2018The studyFDA approval based primarily on data from global, multi-queue, Ib EQUULEUS (MMY1001) studiesThe study assessed differences in daratumumab combination of multiple therapiesresults showed that the first dose of daratumab was divided into two injections, which effectively shortened the infusion time, and the type and incidence of adverse reactions were similarIn addition, the pharmacokinetic concentration of daratumab after 1 week is comparable, whether it is a single intravenous infusion or two infusions
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
